Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Monte Rosa Therapeutics Q1 EPS $0.57 Beats $(0.30) Estimate, Sales $84.93M Beat $14.25M Estimate

Author: Benzinga Newsdesk | May 08, 2025 07:24am
Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $(0.30) by 290 percent. This is a 207.55 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $84.93 million which beat the analyst consensus estimate of $14.25 million by 495.99 percent. This is a 7.88K percent increase over sales of $1.06 million the same period last year.

Posted In: GLUE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist